Frequent musculoskeletal pain is linked with an increased risk of exiting work and retiring earlier, according to a new study from the University of Portsmouth.
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence – Pharmaceutical Technology
Biogen’s acquisition of HI-Bio’s anti-CD38 monoclonal antibody will expand its immunology presence. Image credit: Shutterstock / Tada Images. As Eli Lilly’s Kisunla (donanemab) enters the